Pathologists
Capture revenue and visibility on every molecular send-out. Move from manual coordination to a single guided workflow with built-in chain-of-custody, FMV compensation, and performance analytics.
For source labs →
A Lab Angelus platform
A coordinated path for every specimen.
LabDispatch is the digital coordination platform connecting community pathology laboratories with the nation's leading molecular reference laboratories — bringing precision oncology testing into a single, traceable workflow.
The platform
The connective infrastructure of precision oncology.
LabDispatch coordinates the full specimen journey — from a pathologist's slide to a reference lab's sequencer to the oncologist's treatment decision. One platform. Three audiences. Every handoff accounted for.
First commercial deployment
Live integration underway with a publicly traded molecular diagnostics partner — a category leader in cancer reference testing.
Network access
Available through the Independent Pathology Practice Network (IPPN) — 27 pathology groups, 579 pathologists nationwide.
Compliance posture
HIPAA-aligned, HL7 FHIR interoperable, architected from inception for AKS Safe Harbor and SOC 2 readiness.
2M+
New cancer diagnoses annually in the United States.
65%
Of eligible cancer patients currently miss complete molecular profiling.
10+
Disconnected lab portals an oncology practice may juggle today.
1
Coordinated interface — that's the LabDispatch answer.
For three audiences
One platform, calibrated for each side of the workflow.
LabDispatch removes the friction that has historically lived between community pathology, molecular reference laboratories, and the oncologists who depend on both. Each audience sees only what they need — but the work is now coordinated end-to-end.
Reference Labs
Reach hundreds of community pathology practices through one integration. Reduce customer acquisition cost, accelerate time-to-first-specimen, and gain quality signal on every case.
For reference labs →Oncologists
Order any molecular test from any partnered lab in one place. Watch the specimen move in real time. Receive results in a single, structured feed — not buried in disconnected portals.
For oncologists →How it works
A linear path through a non-linear problem.
Four moments. One platform. Every step is visible to the people who need it, and audited for the people who require it.
Order
Oncologist or pathologist initiates the molecular test order from a unified interface — no portal hunting, no faxed requisitions.
Route
The platform's routing logic recommends the optimal reference lab by test menu, coverage, turnaround time, and prior performance.
Dispatch
The source lab prepares the specimen with barcode-based chain-of-custody. Logistics integrate directly with courier services.
Result
Reference lab transmits the structured report. The platform delivers it to the ordering oncologist with full audit trail intact.
Compliance-first architecture
Engineered for the standards your patients deserve.
LabDispatch was architected from day one to satisfy the Anti-Kickback Statute Personal Services Safe Harbor, HIPAA Business Associate obligations, HL7 FHIR interoperability standards, and the SOC 2 Type II controls expected of mature healthcare infrastructure.
Review our framework →See it in your workflow.
A 30-minute walkthrough is the fastest way to evaluate fit. We'll bring the data; you bring the questions.
For community pathology
Stop sending tissue into the void.
Every send-out specimen represents downstream clinical value — and downstream revenue. LabDispatch is the first platform built for community pathology to capture both. With built-in compliance, transparent compensation, and analytics that surface what was previously invisible.
For two decades, community pathology has been the connective tissue of cancer care without the recognition — or the data infrastructure — to match. LabDispatch changes that equation.— Samuel Caughron, MD · Co-Founder & Managing Principal
$200
Typical per-specimen FMV compensation for source lab logistics services.
27
IPPN member groups already engaged with the platform pathway.
579
Pathologists in the IPPN network — the largest independent practice coalition in the country.
What it does
A platform built around how community pathology actually works.
Most software for the laboratory was designed for the destination — the academic medical center, the reference lab, the integrated health system. LabDispatch starts at the source: the practice handling the case, preparing the specimen, and waiting for results that never seem to close the loop.
Fair Market Value compensation
Transparent, independently determined payment for the real work of specimen preparation and dispatch — structured to satisfy AKS Personal Services Safe Harbor requirements.
Automated reference lab routing
The platform recommends the optimal destination by test menu, insurance coverage, turnaround time, and prior performance — without removing pathologist judgment.
Digital requisitions, end to end
Auto-populated forms eliminate manual data entry. Barcode-based chain-of-custody travels with every specimen and reconciles on receipt.
Performance dashboards
Visibility into send-out volume, turnaround time, specimen quality, and oncologist satisfaction — finally a defensible record of the value your lab delivers.
Workflow that fits
Designed for community pathology realities — modest IT footprint, integrations with major LIS systems (CoPath, Lightning, others), and onboarding measured in days, not quarters.
Compliance handled
HIPAA Business Associate Agreements in place, AKS Safe Harbor framework documented, and an independent fair market value determination on file for every fee category.
Find out what your lab is owed.
A short conversation tells you whether LabDispatch fits your operation. We come prepared with workflow specifics and revenue modeling for groups your size.
For molecular reference laboratories
One integration. Hundreds of pathology practices.
Direct sales into community pathology is slow, expensive, and inconsistent. LabDispatch is the compliant channel that puts your test menu in front of practices already organized into a network — at a fraction of the cost of acquiring them one by one.
Customer acquisition
Industry data places destination-lab CAC at $5,000–$10,000 per source lab relationship. The platform reduces that ratio dramatically.
Time to first specimen
From onboarded source lab to first sequenceable specimen, measured in days. No bespoke integration project.
Channel posture
Open platform; no exclusivity required. Early partners shape the default workflow as the standard solidifies.
50–70%
Customer acquisition cost reduction versus direct community pathology outreach.
1×
Integration. One technical lift, applied across every source lab on the network.
100+
Target source labs across IPPN and adjacent networks within 24 months.
30K+
Specimen throughput target for the first cohort of partnered reference labs.
What it does for you
Distribution. Quality signal. Compliant by design.
Reference labs spend extraordinary resources finding their next specimen. The platform replaces that grind with structural distribution into pathology practices that already see the cases — and a quality framework that makes every shipment a defensible event.
Lead generation engine
Automated connection to source labs actively seeking partnered molecular testing services. Inbound interest, qualified by workflow context, not cold outreach.
Specimen quality management
Pre-shipment verification of tissue adequacy and handling requirements. Fewer rejected specimens. Fewer redrawn cases. Faster results.
Direct logistics integration
Native connections to FedEx, UPS, and specialized medical couriers. Specimen status, in real time, with no separate tracking systems.
Structured result delivery
Digital transmission of reports to ordering oncologists through the same unified interface, with audit trails that close the loop on every case.
In-platform visibility
Optional co-branding, educational modules, and clinical updates targeted to pathologists and oncologists already engaged in your workflow.
Compliant channel architecture
The platform is structured so payments flow only against documented, FMV-determined services. Source labs pay their own platform costs — no inducement, no exposure.
Anti-Kickback Statute
Built around the Personal Services Safe Harbor.
Reference lab partners receive documentation of the platform's compliance architecture, including independent third-party FMV determinations for every fee category, the conflict-of-interest policy governing source-lab ownership, and the Business Associate framework for HIPAA. Your compliance counsel will recognize the structure immediately.
Compliance framework →Talk to the team.
Reference lab partnerships are scoped through a short qualifying conversation, a technical fit assessment, and a documented compliance review. Two weeks from first contact to decision is typical.
For oncologists
Every test, every lab, every result — in one place.
Treatment decisions wait on results. Results wait on portals. Portals wait on faxes. LabDispatch removes the stops between you and the information you need to make the right call at the right moment.
The administrative weight
An oncology practice may navigate ten or more separate molecular lab portals — each with its own credentials, formats, and quirks. LabDispatch consolidates them.
Time to treatment
For metastatic disease, every day between order and result is a day of clinical risk. The platform was designed to surface bottlenecks, not hide them.
Cost to your practice
Reference labs cover the platform fees — there is no charge to oncology practices for ordering, tracking, or receiving results through LabDispatch.
What you see
A single interface designed for clinical pace.
No new login per lab. No reconciling three formats of the same result. No staff member spending half a morning chasing a status update. The platform was designed so the screen never gets in the way of the patient.
Unified test ordering
Order any molecular test from any partnered reference lab through a single guided interface. Insurance verification and coverage checks happen before the order leaves your desk.
Real-time specimen tracking
Specimen location and testing status update live — from source lab to courier to reference lab to result. No more phone calls to find out where a case stands.
Structured result delivery
All molecular results in a consistent, standardized format. Genomic findings, biomarker status, and reportable variants surfaced where they should be — at the top.
Clinical decision support
Treatment algorithm references and clinical trial matching surfaced alongside results, so the next step is one click away instead of an afternoon of cross-referencing.
Designed for your workflow
FHIR-based interoperability with major EHR systems. The platform meets your practice where it already operates — Epic, Cerner, and others.
Patient-centered audit trail
Every step in a specimen's journey is timestamped and queryable. Disputes about turnaround, ordering, or delivery have a record now — not a memory.
The problem was never the testing. The problem was always the coordination around the testing. That is what the platform fixes — and that is why oncology will adopt it quickly once they see it.— Field interview · community oncologist · Kansas City metro
See it in your clinic.
A 20-minute demo with a member of the LabDispatch team is the fastest way to evaluate whether this fits your practice. We come prepared with the workflow specifics for groups your size.
Security & compliance
Architected for the standards your patients deserve.
LabDispatch operates at the intersection of three of the most heavily regulated domains in healthcare — protected health information, anti-kickback law, and laboratory accreditation. The platform was designed from the first line of code to meet each on its own terms.
Legal counsel
Health law: Randal Schultz, Lathrop GPM. The platform's compliance architecture is reviewed and documented by outside counsel with deep laboratory and pathology law expertise.
Independent validation
Third-party fair market value determinations are obtained for every fee category. The methodology is documented and made available to compliance reviewers on request.
Five pillars
Compliance is not a feature. It is the foundation.
Healthcare technology in 2026 is judged by what happens when a regulator, an auditor, or an in-house counsel actually looks. The pillars below describe how the platform answers each line of inquiry.
HIPAA
Business Associate posture
LabDispatch operates as a HIPAA Business Associate with every participating laboratory and clinical practice. BAAs in place, technical safeguards aligned with the Security Rule, audit logging on every data touch.
AKS
Personal Services Safe Harbor
Fee structures are documented to satisfy the Anti-Kickback Statute Personal Services and Management Contracts Safe Harbor, including written agreements, set-in-advance compensation, FMV pricing, and arm's-length structuring.
SOC 2
Type II readiness
The platform's security controls are designed against the SOC 2 Trust Services Criteria — security, availability, confidentiality, and processing integrity. Type II audit is on the production roadmap.
FHIR
HL7 FHIR interoperability
Native support for HL7 FHIR resources for orders, specimens, and reports. Integration with major EHR systems (Epic, Cerner) and laboratory information systems (CoPath, Lightning) is a design assumption, not a special case.
FMV
Independent FMV determinations
Every fee category — setup, license, per-specimen — is supported by an independent fair market value determination from a recognized healthcare valuation firm. Determinations are refreshed on a defined cadence.
COI
Conflict of interest policy
The platform's governance includes a written conflict of interest policy with mandatory recusal procedures for any decision implicating personnel with ownership interests in participating laboratories.
Architecture summary
Technical posture, in brief.
-
INFRASTRUCTURE
HIPAA-aligned cloud infrastructure with end-to-end encryption in transit (TLS 1.3) and at rest (AES-256).
-
ACCESS
Role-based access controls with multi-factor authentication and session timeouts calibrated to clinical environments.
-
AUDIT
Immutable audit logging on every data event, queryable by authorized compliance reviewers without engineering intervention.
-
EXCLUSIONS
OIG List of Excluded Individuals/Entities and SAM debarment screening on every new platform participant.
-
DE-IDENTIFICATION
When and if data analytics are introduced, they follow the HIPAA Safe Harbor de-identification methodology with an independent expert determination on file.
Need to see the documentation?
Qualified counsel and compliance officers can request the platform's full compliance package, including the AKS framework, the FMV methodology, and our BAA template.
Get in touch
Tell us about your lab, your practice, or your inquiry.
We respond to every legitimate inbound within one business day. Pathology groups, reference labs, oncology practices, health system administrators, and strategic partners are all welcome here.
Mailing address
LabDispatch / Lab Angelus, LLC
1415 Main Street
Grandview, Missouri 64030
Strategic inquiries
For corporate, partnership, or other strategic matters, please write to the Office of the CEO at info@labangelus.com.